Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06399302 · ClinicalTrials.gov registry record
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
A clinical trial of Lung Transplant; Complications and Lung Transplant Rejection, sponsored by Duke University.
- Recruiting
- Registry status
- 2,600
- Enrollment target
- 17
- Study locations
NCT06399302: Recruiting study of Lung Transplant; Complications and Lung Transplant Rejection, sponsored by Duke University.
NCT06399302 is a study of Lung Transplant; Complications and Lung Transplant Rejection that is actively recruiting participants, run by Duke University. The registered enrollment target is 2,600 participants, above the 143-participant average among 6 other Lung Transplant; Complications trials with a reported enrollment target (1718% higher). The trial reports 17 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06399302, a study of Lung Transplant; Complications and Lung Transplant Rejection, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 2,600 participants
- Enrollment target
- 17
- Study locations
Study Summary
This project aims to collect detailed clinical data, blood samples, and patient-reported outcomes from 2,600 lung transplant candidates, donors, and recipients at Lung Transplant Centers. The goal is to create a robust resource for various research objectives, including studying the impact of variations in donor and medical practices on clinical outcomes. The project also seeks to identify serum biomarkers associated with or predictive of specific post-transplant complications and conditions.
Primary Outcome
To collect detailed clinical data, blood samples (including DNA), and PROs in 2,600 lung transplant candidates, donors, and recipients across the participating LTC centers to create a robust resource that will support a broad range of additional future clinical and translational research objectives
Conditions Studied
Study Locations (17)
California
- University of California Los Angeles - Los Angeles
- University of California at San Francisco - San Francisco
New York
- New York University - New York
- Columbia University - New York
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Florida
- University of Miami - Miami
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Brigham and Womens Hospital - Boston
Michigan
- University of Michigan - Ann Arbor
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,600 participants |
| Start Date | 2024-09-03 |
| Est. Completion | 2027-06-30 |
What NCT06399302 shows while recruiting
NCT06399302 is an observational study that tracks outcomes without assigning an intervention. Its 2,600 participants enrollment target places it among the larger protocols in the corpus, above the 143-participant average among 6 other Lung Transplant; Complications trials with a reported enrollment target (1718% higher).
The record links to 4 conditions, with Lung Transplant; Complications appearing as the primary indexed condition, and to 0 interventions.
NCT06399302 lists 17 locations in 14 states (California, New York, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT06399302 about?
NCT06399302 is a clinical study titled "Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes". This project aims to collect detailed clinical data, blood samples, and patient-reported outcomes from 2,600 lung transplant candidates, donors, and recipients at Lung Transplant Centers. The goal is to create a robust resource for various research objectives, including studying the impact of variat...
What is the current status of trial NCT06399302?
This trial is currently recruiting. The enrollment target is 2,600 participants. The study started on 2024-09-03. Estimated completion is 2027-06-30.
What conditions does trial NCT06399302 study?
This clinical trial studies the following conditions: Lung Transplant; Complications, Lung Transplant Rejection, Lung Transplant; Infection or Inflammation, Lung Transplant Failure.
Who is sponsoring clinical trial NCT06399302?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06399302 being conducted?
This trial has 17 study locations across California, Florida, Maryland, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Transplant; Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
RECRUITING · Early Phase 1
-
CMV Immunity Monitoring in Lung Transplant Recipients
RECRUITING · Phase 2
-
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
ACTIVE NOT RECRUITING · NA
-
AlloSure Lung Assessment and Metagenomics Outcomes Study
ACTIVE NOT RECRUITING
-
Preventing Rehospitalization in Lung Transplant Recipients Utilizing mHealth
COMPLETED · NA
-
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
- NCT06370520 · 2,592 participants
Screening Emotions in Adolescents at the Hospital for mTBI
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI